Rockefeller Capital Management L.P. Novartis Ag Transaction History

Rockefeller Capital Management L.P.

  • $36.3 Billion
  • Q3 2024

A detailed history of Rockefeller Capital Management L.P. transactions in Novartis Ag stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 105,613 shares of NVS stock, worth $11 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
105,613
Previous 110,523 4.44%
Holding current value
$11 Million
Previous $11.8 Million 3.24%
% of portfolio
0.03%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$106.13 - $120.89 $521,098 - $593,569
-4,910 Reduced 4.44%
105,613 $12.1 Million
Q2 2024

Aug 12, 2024
SELL
$92.57 - $107.37 $3.54 Million - $4.1 Million
-38,218 Reduced 25.69%
110,523 $11.8 Million
Q1 2024

May 14, 2024
BUY
$95.27 - $108.47 $4.47 Million - $5.09 Million
46,960 Added 46.14%
148,741 $14.4 Million
Q4 2023

Feb 14, 2024
SELL
$92.27 - $101.54 $2.28 Million - $2.51 Million
-24,750 Reduced 19.56%
101,781 $10.3 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $6.66 Million - $7.39 Million
-70,296 Reduced 35.71%
126,531 $12.9 Million
Q2 2023

Aug 14, 2023
BUY
$92.52 - $104.91 $362,493 - $411,037
3,918 Added 2.03%
196,827 $19.9 Million
Q1 2023

May 17, 2023
SELL
$80.03 - $92.81 $1.65 Million - $1.92 Million
-20,676 Reduced 9.68%
192,909 $17.7 Million
Q4 2022

Mar 06, 2023
SELL
$75.55 - $92.52 $18,358 - $22,482
-243 Reduced 0.11%
213,585 $19.4 Million
Q3 2022

Nov 02, 2022
SELL
$74.61 - $87.26 $39,170 - $45,811
-525 Reduced 0.24%
213,828 $16.3 Million
Q2 2022

Aug 12, 2022
BUY
$80.52 - $93.75 $1.05 Million - $1.23 Million
13,074 Added 6.5%
214,353 $18.1 Million
Q1 2022

May 13, 2022
SELL
$80.11 - $90.62 $1.78 Million - $2.02 Million
-22,266 Reduced 9.96%
201,279 $17.7 Million
Q4 2021

Feb 14, 2022
BUY
$79.7 - $88.13 $1.08 Million - $1.19 Million
13,505 Added 6.43%
223,545 $19.6 Million
Q3 2021

Nov 12, 2021
BUY
$81.78 - $95.14 $750,249 - $872,814
9,174 Added 4.57%
210,040 $17.2 Million
Q2 2021

Aug 10, 2021
BUY
$85.24 - $94.15 $5.76 Million - $6.36 Million
67,553 Added 50.67%
200,866 $18.3 Million
Q1 2021

May 11, 2021
BUY
$83.5 - $98.47 $2.44 Million - $2.87 Million
29,186 Added 28.03%
133,313 $11.4 Million
Q4 2020

Feb 12, 2021
SELL
$78.07 - $94.43 $3.69 Million - $4.46 Million
-47,264 Reduced 31.22%
104,127 $9.83 Million
Q3 2020

Nov 13, 2020
SELL
$82.14 - $91.0 $60.8 Million - $67.4 Million
-740,514 Reduced 83.03%
151,391 $13.2 Million
Q2 2020

Aug 12, 2020
SELL
$80.93 - $91.1 $22.4 Million - $25.3 Million
-277,255 Reduced 23.71%
891,905 $77.9 Million
Q1 2020

May 12, 2020
SELL
$70.67 - $99.01 $4.96 Million - $6.95 Million
-70,193 Reduced 5.66%
1,169,160 $96.4 Million
Q4 2019

Feb 07, 2020
SELL
$84.35 - $95.37 $1.58 Million - $1.79 Million
-18,723 Reduced 1.49%
1,239,353 $117 Million
Q3 2019

Nov 12, 2019
BUY
$85.54 - $94.26 $781,236 - $860,876
9,133 Added 0.73%
1,258,076 $109 Million
Q2 2019

Aug 09, 2019
SELL
$75.4 - $92.8 $914,300 - $1.13 Million
-12,126 Reduced 0.96%
1,248,943 $114 Million
Q1 2019

May 10, 2019
BUY
$75.32 - $86.15 $726,084 - $830,486
9,640 Added 0.77%
1,261,069 $121 Million
Q4 2018

Feb 12, 2019
BUY
$73.66 - $82.02 $2.89 Million - $3.22 Million
39,244 Added 3.24%
1,251,429 $107 Million
Q3 2018

Nov 02, 2018
BUY
$66.94 - $77.43 $14.9 Million - $17.2 Million
222,141 Added 22.44%
1,212,185 $104 Million
Q2 2018

Jul 31, 2018
SELL
$64.91 - $73.36 $846,101 - $956,247
-13,035 Reduced 1.3%
990,044 $74.8 Million
Q1 2018

May 09, 2018
BUY
$70.39 - $84.15 $70.6 Million - $84.4 Million
1,003,079 New
1,003,079 $81.1 Million

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email